ESMO TAT 2022 | Unmet needs for early onset colorectal cancer

There has been a significant increase in early onset colorectal cancer (EO-CRC) over the last 10 years. Elisa Fontana, MD, PhD, Sarah Cannon Research Institute UK, London, UK, discusses recent research into the incidence of EO-CRC across Europe, and what research needs to be done to improve outcomes for these patients. This interview was conducted at the virtual European Society for Medical Oncology Targeted Anti-Cancer Therapies (ESMO TAT) Congress 2022.